Prodigy Asset Management Q2 2026 Portfolio Activity: Significant Increases and Minor Adjustments Observed
Prodigy Asset Management's portfolio value reached $332.1 million as of June 30, 2026. The firm demonstrated notable buying activity in several stocks while slightly reducing its position in others.
As of June 30, 2026, Prodigy Asset Management LLC maintained a substantial portfolio valued at $332.05 million.
The investment strategy for Q2 appears to have focused on strengthening positions in large-cap entities and ETFs while trimming some holdings slightly. Notably, the fund significantly increased its stake in GMO ETF Trust (QLTY), boosting its allocation from 14.67% down to a higher percentage.
Among the most significant purchases this quarter was BRK-B, which saw its position grow by approximately $283,000 or 10.95%, increasing its portfolio weight substantially despite a nominal share count change (-11.24%).
The fund also demonstrated strong interest in Vanguard Specialized Funds (VIG), adding nearly $1 million worth of shares during the quarter.
Conversely, Prodigy slightly reduced its position in Morgan Stanley ETF Trust (EVTR) by 0.61%, though this represented a very small change relative to their overall portfolio size.
In addition to these adjustments, two new individual stock positions were established: Mannkind Corp (MNKD) and Eledon Pharmaceuticals Inc. (ELDN).